ArticleMedicine2026
Bilateral proptosis as the first manifestation in a patient with acute myeloid leukemia: Case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleMyeloid sarcoma (MS), also known as granulocytic sarcoma or chloroma, is a rare manifestation of acute myeloid leukemia (AML) that occurs concurrently with, following, or rarely before the onset of leukemia. It consists of immature myeloid cells that proliferate in extramedullary tissues. Owing to the rare association between bilateral proptosis and AML, it is often misdiagnosed as other conditions that present with proptosis, such as infections (as in our case), vascular lesions, or tumors, particularly rhabdomyosarcoma and neuroblastoma, creating a diagnostic dilemma. PATIENT CONCERNS: We report a case of MS that initially presented with bilateral proptosis and was misdiagnosed as orbital cellulitis. A child of Syrian origin presented with rapidly progressive bilateral proptosis that had started 2 weeks prior to admission. Her medical history was unremarkable except for a blood transfusion 2 months earlier. She initially received treatment for suspected conjunctivitis and then for orbital cellulitis with intravenous antibiotics, with no clinical improvement. On examination, she appeared pale and fatigued. Ophthalmic examination revealed severe bilateral eyelid edema with proptosis and conjunctival chemosis. DIAGNOSES AND
interventionsMS was diagnosed based on laboratory tests, bone marrow examination, and computed tomography imaging. A complete response was achieved dramatically after 1 month of treatment with the standard chemotherapy regimen. OUTCOMES: This case highlights the various aspects of AML in children and aims to draw clinicians' attention to the possible diagnosis of AML in a patient with proptosis, which may lead to earlier diagnosis and treatment. LESSONS: This case raises awareness among clinicians to consider AML in the differential diagnosis of any child with unilateral or bilateral proptosis, even in the absence of systemic symptoms of leukemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.